- active not recruitingPHASE3
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine called BLU-5937 for adults with a stubborn, long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough, compared to a dummy pill.
United States · Argentina · Belgium - recruiting
Development of a Cough Control Questionnaire (CCQ)
This study is developing a new questionnaire to better understand and measure how cough affects people's lives. It aims to help doctors and researchers accurately track changes in cough severity and how well treatments are working, similar to tools used for other lung conditions like asthma.
United Kingdom - active not recruitingPHASE3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine, BLU-5937, for adults in the UK with a long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough over 24 weeks, compared to a dummy pill.
United States · Australia · Canada